B. Riley FBR analyst Randy Binner upgraded Health Insurance Innovations to Buy from Neutral with an unchanged price target of $45. The analyst cites the recent pullback in the shares as well as the company’s growth outlook for the upgrade to Buy. He sees an attractive valuation at current stock levels.
https://thefly.com/landingPageNews.php?id=2880307
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.